Urine and Serum Cathepsin B Concentrations in the Transitional Cell Carcinoma of the Bladder

Journal of Clinical Laboratory Analysis

Volumn 26, Issue 2, 2012, Pages 61-65

  Kotaska, Karel ^a   Dusek, Pavel ^a   Prusa, Richard ^a   Vesely, Stepan ^a   Babjuk, Marek ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Bladder; Cathepsin B; Invasive; Noninvasive tumors; Transitional cell carcinoma

Indexed keywords

CATHEPSIN B; CREATININE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; TRANSITIONAL CELL CARCINOMA; URINE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CATHEPSIN B; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84859206846     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21483     Document Type: Article

References (21)

1. Barrett AJ, Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 1981;80 Pt C:535-561.
2. Uchiyama H, Anderson KC. Cellular adhesion molecules. Transfus Med Rev 1994;8(2):84-95.
3. Calkins CC, Sloane BF. Mammalian cysteine protease inhibitors: Biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995;376(2):71-80.
4. Yan S, Sloane BF. Molecular regulation of human cathepsin B: Implication in pathologies. Biol Chem 2003;384(6):845-854.
5. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms: Incidence and survival during the last 2 decades. J Urol 2000;164(5):1523-1525.
6. Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol 2009;27(3):289-293.
7. Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54(2):303-314.
8. Soloway MS. Overview of treatment of superficial bladder cancer. Urology 1985;26(Suppl 4):18-26.
9. Staack A, Koenig F, Daniltchenko D, Hauptmann S, Loening SA, Schnorr D, Jung K. Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder. Urology 2002;59(2):308-312.
10. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22(12):1435-1448.
11. Sobin LCW. TNM Classification of Malignant Tumours, Sixth Edition. Sobin LCW, editors. New York: Wiley-Liss; 2002.
12. Eijan AM, Sandes E, Puricelli L, Bal De Kier Joffe E, Casabe AR. Cathepsin B levels in urine from bladder cancer patients. Oncol Rep 2000;7(6):1395-1399.
13. Eijan AM, Sandes EO, Riveros MD, Thompson S, Pasik L, Mallagrino H, Celeste F, Casabe AR. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion. Cancer 2003;98(2):262-268.
14. Svatek RS, Karam J, Karakiewicz PI, Gallina A, Casella R, Roehrborn CG, Shariat SF. Role of urinary cathepsin B andL in the detection of bladder urothelial cell carcinoma. J Urol 2008;179(2):478-484; discussion 484.
15. Staack A, Tolic D, Kristiansen G, Schnorr D, Loening SA, Jung K. Expression of cathepsins B, H, and L and their inhibitors as markers of transitional cell carcinoma of the bladder. Urology 2004;63(6):1089-1094.
16. Hopkins SC, Ford KS, Soloway MS. Invasive bladder cancer: Support for screening. J Urol 1983;130(1):61-64.
17. Eng C, Cunningham D, Quade BJ, Schwamm L, Kantoff PW, Skarin AT. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer 1993;72(2):553-557.
18. Kishi K, Hirota T, Matsumoto K, Kakizoe T, Murase T, Fujita J. Carcinoma of the bladder: A clinical and pathological analysis of 87 autopsy cases. J Urol 1981;125(1):36-39.
19. Rosenstein M, Wallner K, Scher H, Sternberg CN. Treatment of brain metastases from bladder cancer. J Urol 1993;149(3):480-483.
20. Akpolat I, Baris YS, Yilmaz AF, Bakirtas M, Saylik A, Karagoz F, Kandemir B. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma. Neoplasma 1998;45(6):365-368.
21. Ueda M. [A study on cathepsin B-like substance in patients with urological cancer]. Nippon Hinyokika Gakkai Zasshi 1993;84(2):355-363.